Viewing StudyNCT00002663



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002663
Status: COMPLETED
Last Update Posted: 2023-02-13
First Post: 1999-11-01

Brief Title: Biological Therapy in Treating Patients at High-Risk or With Lymphoma Lymphoproliferative Disease or Malignancies
Sponsor: Atara Biotherapeutics
Organization: Atara Biotherapeutics

Organization Data

Organization: Atara Biotherapeutics
Class: INDUSTRY
Study ID: 95-024
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Atara Biotherapeutics
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH
Memorial Sloan Kettering Cancer Center OTHER